Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01932034 · ClinicalTrials.gov registry record
Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software
A clinical trial, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- 263
- Enrollment target
NCT01932034 is a clinical trial that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 263 participants.
The verdict
NCT01932034 has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- 263 participants
- Enrollment target
Study Summary
We will compare the percentage of patients having therapeutic vancomycin serum concentrations after current standard dosing, after dosing with our software. We will also include therapeutic outcomes and costs in the analysis.
Interventions
- DEVICE BestDose Computer Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-07-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01932034
The ClinicalTrials.gov registry entry for NCT01932034 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BestDose Computer Software is the first listed.
NCT01932034 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01932034 about?
NCT01932034 is a clinical study titled "Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software". We will compare the percentage of patients having therapeutic vancomycin serum concentrations after current standard dosing, after dosing with our software. We will also include therapeutic outcomes and costs in the analysis.
What is the current status of trial NCT01932034?
This trial is currently completed. The enrollment target is 263 participants. The study started on 2012-09. Estimated completion is 2016-07-04.
What interventions are being tested in trial NCT01932034?
The interventions under investigation include: BestDose Computer Software (DEVICE).
Who is sponsoring clinical trial NCT01932034?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.